The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE
Philadelphia, Pennsylvania -
Newsfile Corp. - May 22, 2025 - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is pleased to announce that it has received study may proceed approval from the UAE DOH...
Read more: Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates Department of...